A Study to Evaluate the Efficacy and Safety of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis
Clinical trial NCT04552899 · TERMINATED
Trial details
- NCT number
- NCT04552899
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-19
- Primary completion
- 2023-02-10
- Enrollment
- 665
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.